News & Updates

Monitoring the body weight of the BMI of patients taking antidepressants does not seem to fully capture the adverse changes in body composition, a study has found. Such changes may result in a worsened cardiometabolic risk profile.

Early and intensive glycaemic control continues to reduce risks of mortality, MI, and microvascular complications even at 44 years after the UKPDS study’s initiation, according to follow-up data presented at the EMW Symposium 2024.

Hypertension, regardless of blood pressure control, appears to exert a negative influence on fecundability in women, as reported in a study.

Sacubitril/valsartan appears to be safe and beneficial in the treatment of children with heart failure (HF) attributable to systemic left ventricular systolic dysfunction (LVSD), with the drug having comparable efficacy as enalapril, according to the 52-week data from the phase 2/3 PANORAMA-HF* trial.